Quantification of the brain proteome in Alzheimer's disease using multiplexed mass spectrometry

Journal of Proteome Research

Volumn 13, Issue 4, 2014, Pages 2056-2068

  Musunuri, Sravani ^a   Wetterhall, Magnus ^a   Ingelsson, Martin ^b   Lannfelt, Lars ^b   Artemenko, Konstantin ^a   Bergquist, Jonas ^a   Kultima, Kim ^c   Shevchenko, Ganna ^a  

^a Department of Chemistry BMC   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease (AD); brain tissue; dimethyl labeling (DML); mass spectrometry (MS); quantitative proteomics

Indexed keywords

ACETYL COENZYME A ACETYLTRANSFERASE; APOLIPOPROTEIN D; BRAIN PROTEIN; CALPHOBINDIN II; CARBONATE DEHYDRATASE II; CATHEPSIN D; CLATHRIN HEAVY CHAIN; CLATHRIN HEAVY CHAIN 1; COFILIN 1; CYTOCHROME C; DIHYDROPTERIDINE REDUCTASE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE; LIPOCORTIN 5; MALATE DEHYDROGENASE; NEUROTRIMIN; OXIDOREDUCTASE; PEROXIREDOXIN 1; PEROXIREDOXIN 2; PEROXIREDOXIN 6; SEPTIN; SEPTIN 2; SEPTIN 3; SEPTIN 5; SERUM ALBUMIN; STABLE ISOTOPE; SYNAPSIN I; SYNDAPIN 1; SYNTAXIN 1A; TRANSKETOLASE; UNCLASSIFIED DRUG; NERVE PROTEIN; PROTEOME;

ADULT; AGED; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BRAIN TISSUE; CEREBROSPINAL FLUID; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; FEMALE; GLYCOLYSIS; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; MASS SPECTROMETRY; MULTIPLEXED MASS SPECTROMETRY; NEOCORTEX; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION; STRESS; VERY ELDERLY; BRAIN LEVEL; CHEMISTRY; CLASSIFICATION; METABOLISM; MIDDLE AGED; PROCEDURES; PROTEOMICS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN CHEMISTRY; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; NERVE TISSUE PROTEINS; PROTEOME; PROTEOMICS;

EID: 84898767050     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr401202d     Document Type: Article

References (90)

1. Blennow, K.; de Leon, M. J.; Zetterberg, H. Alzheimer's disease Lancet 2006, 368 (9533) 387-403
2. Tomlinso, Be; Blessed, G.; Roth, M. Observations on brains of demented old people J. Neurol. Sci. 1970, 11 (3) 205-&
3. Hardy, J. A.; Higgins, G. A. Alzheimers disease-the amyloid cascade hypothesis Science 1992, 256 (5054) 184-185
4. Swerdlow, R. H.; Burns, J. M.; Khan, S. M. The Alzheimer's disease mitochondrial cascade hypothesis J. Alzheimers Dis. 2010, 20, S265-S279
5. Akiyama, H.; Barger, S.; Barnum, S.; Bradt, B.; Bauer, J.; Cole, G. M.; Cooper, N. R.; Eikelenboom, P.; Emmerling, M.; Fiebich, B. L.; Finch, C. E.; Frautschy, S.; Griffin, W. S. T.; Hampel, H.; Hull, M.; Landreth, G.; Lue, L. F.; Mrak, R.; Mackenzie, I. R.; McGeer, P. L.; O'Banion, M. K.; Pachter, J.; Pasinetti, G.; Plata-Salaman, C.; Rogers, J.; Rydel, R.; Shen, Y.; Streit, W.; Strohmeyer, R.; Tooyoma, I.; Van Muiswinkel, F. L.; Veerhuis, R.; Walker, D.; Webster, S.; Wegrzyniak, B.; Wenk, G.; Wyss-Coray, T. Inflammation and Alzheimer's disease Neurobiol. Aging 2000, 21 (3) 383-421
6. Blennow, K.; Wallin, A.; Agren, H.; Spenger, C.; Siegfried, J.; Vanmechelen, E. tau protein in cerebrospinal fluid-A biochemical marker for axonal degeneration in Alzheimer disease? Mol. Chem. Neuropathol. 1995, 26 (3) 231-245
7. Jensen, M.; Schroder, J.; Blomberg, M.; Engvall, B.; Pantel, J.; Ida, N.; Basun, H.; Wahlund, L. O.; Werle, E.; Jauss, M.; Beyreuther, K.; Lannfelt, L.; Hartmann, T. Cerebrospinal fluid A beta 42 is increased early in sporadic Alzheimer's disease and declines with disease progression Ann. Neurol. 1999, 45 (4) 504-511
8. Lindh, M.; Blomberg, M.; Jensen, M.; Basun, H.; Lannfelt, L.; Engvall, B.; Scharnagel, H.; Marz, W.; Wahlund, L. O.; Cowburn, R. F. Cerebrospinal fluid apolipoprotein E (apoE) levels in Alzheimer's disease patients are increased at follow up and show a correlation with levels of tau protein Neurosci. Lett. 1997, 229 (2) 85-88
9. Hye, A.; Lynham, S.; Thambisetty, M.; Causevic, M.; Campbell, J.; Byers, H. L.; Hooper, C.; Rijsdijk, F.; Tabrizi, S. J.; Banner, S.; Shaw, C. E.; Foy, C.; Poppe, M.; Archer, N.; Hamilton, G.; Powell, J.; Brown, R. G.; Sham, P.; Ward, M.; Lovestone, S. Proteome-based plasma biomarkers for Alzheimer's disease Brain 2006, 129, 3042-3050
10. Ray, S.; Britschgi, M.; Herbert, C.; Takeda-Uchimura, Y.; Boxer, A.; Blennow, K.; Friedman, L. F.; Galasko, D. R.; Jutel, M.; Karydas, A.; Kaye, J. A.; Leszek, J.; Miller, B. L.; Minthon, L.; Quinn, J. F.; Rabinovici, G. D.; Robinson, W. H.; Sabbagh, M. N.; So, Y. T.; Sparks, D. L.; Tabaton, M.; Tinklenberg, J.; Yesavage, J. A.; Tibshirani, R.; Wyss-Coray, T. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins Nat. Med. 2007, 13 (11) 1359-1362
11. Andreev, V. P.; Petyuk, V. A.; Brewer, H. M.; Karpievitch, Y. V.; Xie, F.; Clarke, J.; Camp, D.; Smith, R. D.; Lieberman, A. P.; Albin, R. L.; Nawaz, Z.; El Hokayem, J.; Myers, A. J. Label-free quantitative LC-MS proteomics of Alzheimer's disease and normally aged human brains J. Proteome Res. 2013, 11 (6) 3053-3067
12. Mattila, K. M.; Frey, H. 2-Dimensional analysis of qualitative and quantitative changes in blood-cell proteins in Alzheimers-disease-search for extraneuronal markers Appl. Theor. Electrophor. 1995, 4 (4) 189-196
13. Liu, H. C.; Hu, C. J.; Chang, J. G.; Sung, S. M.; Lee, L. S.; Yuan, R. Y.; Leu, S. J. Proteomic identification of lower apolipoprotein A-I in Alzheimer's disease Dement. Geriatr. Cogn. Disord. 2006, 21 (3) 155-161
14. Juhasz, G.; Foldi, I.; Penke, B. Systems biology of Alzheimer's disease: How diverse molecular changes result in memory impairment in AD Neurochem. Int. 2011, 58 (7) 739-750
15. Sowell, R. A.; Owen, J. B.; Butterfield, D. A. Proteomics in animal models of Alzheimer's and Parkinson's diseases Ageing Res. Rev. 2009, 8 (1) 1-17
16. Korolainen, M. A.; Nyman, T. A.; Aittokallio, T.; Pirttila, T. An update on clinical proteomics in Alzheimer's research J. Neurochem. 2010, 112 (6) 1386-1414
17. Naaby-Hansen, S.; Waterfield, M. D.; Cramer, R. Proteomics-post-genomic cartography to understand gene function Trends Pharmacol. Sci. 2001, 22 (7) 376-384
18. Bantscheff, M.; Schirle, M.; Sweetman, G.; Rick, J.; Kuster, B. Quantitative mass spectrometry in proteomics: a critical review Anal. Bioanal. Chem. 2007, 389 (4) 1017-1031
19. Tannu, N. S.; Hemby, S. E. Methods for proteomics in neuroscience Prog. Brain Res. 2006, 158, 41-82
20. Mann, M.; Hendrickson, R. C.; Pandey, A. Analysis of proteins and proteomes by mass spectrometry Annu. Rev. Biochem. 2001, 70, 437-473
21. Boersema, P. J.; Raijmakers, R.; Lemeer, S.; Mohammed, S.; Heck, A. J. R. Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics Nat. Protoc. 2009, 4 (4) 484-494
22. Ross, P. L.; Huang, Y. L. N.; Marchese, J. N.; Williamson, B.; Parker, K.; Hattan, S.; Khainovski, N.; Pillai, S.; Dey, S.; Daniels, S.; Purkayastha, S.; Juhasz, P.; Martin, S.; Bartlet-Jones, M.; He, F.; Jacobson, A.; Pappin, D. J. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents Mol. Cell. Proteomics 2004, 3 (12) 1154-1169
23. Ong, S. E.; Blagoev, B.; Kratchmarova, I.; Kristensen, D. B.; Steen, H.; Pandey, A.; Mann, M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics Mol. Cell. Proteomics 2002, 1 (5) 376-386
24. Sui, P.; Watanabe, H.; Ossipov, M. H.; Porreca, F.; Bakalkin, G.; Bergquist, J.; Artemenko, K. Dimethyl-labeling-based protein quantification and pathway search: A novel method of spinal cord analysis applicable for neurological studies J. Proteome Res. 2013, 12 (5) 2245-2252
25. Sjodin, M. O.; Wetterhall, M.; Kultima, K.; Artemenko, K. Comparative study of label and label-free techniques using shotgun proteomics for relative protein quantification J. Chromatogr. B: Anal. Technol. Biomed. Life. Sci. 2013, 928, 83-92
26. Mirra, S. S.; Heyman, A.; McKeel, D.; Sumi, S. M.; Crain, B. J.; Brownlee, L. M.; Vogel, F. S.; Hughes, J. P.; Vanbelle, G.; Berg, L. The Consortium to Establish a Registry for Alzheimers-Disease (Cerad) 0.2. Standardization of the neuropathologic assessment of Alzheimers-disease Neurology 1991, 41 (4) 479-486
27. Wetterhall, M.; Shevchenko, G.; Artemenko, K.; Sjodin, M. O. D.; Bergquist, J. Analysis of membrane and hydrophilic proteins simultaneously derived from the mouse brain using cloud-point extraction Anal. Bioanal. Chem. 2011, 400 (9) 2827-2836
28. Mastro, R.; Hall, M. Protein delipidation and precipitation by tri-n-butyl phosphate, acetone, and methanol treatment for isoelectric focusing and two-dimensional gel electrophoresis Anal. Biochem. 1999, 273 (2) 313-315
29. Lowry, O. H.; Rosebrough, N. J.; Farr, A. L.; Randall, R. J. Protein measurement with the folin phenol reagent J. Biol. Chem. 1951, 193 (1) 265-275
30. Burton, E. J.; Barber, R.; Mukaetova-Ladinska, E. B.; Robson, J.; Perry, R. H.; Jaros, E.; Kalaria, R. N.; Obrien, J. T. Medial temporal lobe atrophy on MRI differentiates Alzheimers disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis Brain 2009, 132, 195-203
31. Tischfield, M. A.; Baris, H. N.; Wu, C.; Rudolph, G.; Van Maldergem, L.; He, W.; Chan, W. M.; Andrews, C.; Demer, J. L.; Robertson, R. L.; Mackey, D. A.; Ruddle, J. B.; Bird, T. D.; Gottlob, I.; Pieh, C.; Traboulsi, E. I.; Pomeroy, S. L.; Hunter, D. G.; Soul, J. S.; Newlin, A.; Sabol, L. J.; Doherty, E. J.; de Uzcategui, C. E.; de Uzcategui, N.; Collins, M. L.; Sener, E. C.; Wabbels, B.; Hellebrand, H.; Meitinger, T.; de Berardinis, T.; Magli, A.; Schiavi, C.; Pastore-Trossello, M.; Koc, F.; Wong, A. M.; Levin, A. V.; Geraghty, M. T.; Descartes, M.; Flaherty, M.; Jamieson, R. V.; Moller, H. U.; Meuthen, I.; Callen, D. F.; Kerwin, J.; Lindsay, S.; Meindl, A.; Gupta, M. L., Jr.; Pellman, D.; Engle, E. C. Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance Cell 2010, 140 (1) 74-87
32. Sultana, R.; Perluigi, M.; Newman, S. F.; Pierce, W. M.; Cini, C.; Coccia, R.; Butterfield, D. A. Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease Antioxid. Redox Signaling 2010, 12 (3) 327-336
33. Schonberger, S. J.; Edgar, P. F.; Kydd, R.; Faull, R. L. M.; Cooper, G. J. S. Proteomic analysis of the brain in Alzheimer's disease: Molecular phenotype of a complex disease process Proteomics 2001, 1 (12) 1519-1528
34. Pollak, D.; Cairns, N.; Lubec, G. Cytoskeleton derangement in brain of patients with Down Syndrome, Alzheimer's disease and Pick's disease J. Neural Transm., Suppl. 2003, 67, 149-158
35. Smith, M. A.; Harris, P. L.; Sayre, L. M.; Perry, G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals Proc. Natl. Acad. Sci. U.S.A. 1997, 94 (18) 9866-8
36. Papassotiropoulos, A.; Fountoulakis, M.; Dunckley, T.; Stephan, D. A.; Reiman, E. M. Genetics, transcriptomics, and proteomics of Alzheimer's disease J. Clin. Psychiatry 2006, 67 (4) 652-70
37. Parihar, M. S.; Brewer, G. J. Mitoenergetic failure in Alzheimer disease Am. J. Physiol. Cell Physiol. 2007, 292 (1) C8-C23
38. Lin, M. T.; Beal, M. F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases Nature 2006, 443 (7113) 787-795
39. Ferreira, I. L.; Resende, R.; Ferreiro, E.; Rego, A. C.; Pereira, C. F. Multiple defects in energy metabolism in Alzheimer's disease Curr. Drug Targets 2010, 11 (10) 1193-1206
40. Martin, B.; Brenneman, R.; Becker, K. G.; Gucek, M.; Cole, R. N.; Maudsley, S. iTRAQ analysis of complex proteome alterations in 3xTgAD Alzheimer's mice: Understanding the interface between physiology and disease PLoS One 2008, 3 (7 e2750
41. Takano, M.; Maekura, K.; Otani, M.; Sano, K.; Nakamura-Hirota, T.; Tokuyama, S.; Min, K. S.; Tomiyama, T.; Mori, H.; Matsuyama, S. Proteomic analysis of the brain tissues from a transgenic mouse model of amyloid beta oligomers Neurochem. Int. 2012, 61 (3) 347-355
42. Bubber, P.; Haroutunian, V.; Fisch, G.; Blass, J. P.; Gibson, G. E. Mitochondrial abnormalities in Alzheimer brain: Mechanistic implications Ann. Neurol. 2005, 57 (5) 695-703
43. Mastrogiacomo, F.; Lindsay, J. G.; Bettendorff, L.; Rice, J.; Kish, S. J. Brain protein and α-ketoglutarate dehydrogenase complex activity in Alzheimer's disease Ann. Neurol. 1996, 39 (5) 592-598
44. Kim, S. H.; Vlkolinsky, R.; Cairns, N.; Lubec, G. Decreased levels of complex III core protein 1 and complex V beta chain in brains from patients with Alzheimer's disease and Down syndrome Cell. Mol. Life Sci. 2000, 57 (12) 1810-1816
45. Wisniewski, H. M.; Vorbrodt, A. W.; Wegiel, J. Amyloid angiopathy and blood-brain barrier changes in Alzheimer's disease Ann. N.Y. Acad. Sci. 1997, 826, 161-172
46. Reed, T.; Perluigi, M.; Sultana, R.; Pierce, W. M.; Klein, J. B.; Turner, D. M.; Coccia, R.; Markesbery, W. R.; Butterfield, D. A. Redox proteomic identification of 4-Hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: Insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease Neurobiol. Dis. 2008, 30 (1) 107-120
47. Sultana, R.; Boyd-Kimball, D.; Cai, J.; Pierce, W. M.; Klein, J. B.; Merchant, M.; Butterfield, D. A. Proteomics analysis of the Alzheimer's disease hippocampal proteome J. Alzheimers Dis. 2007, 11 (2) 153-164
48. Messier, C.; Gagnon, M. Glucose regulation and cognitive functions: relation to Alzheimer's disease and diabetes Behav. Brain Res. 1996, 75 (1-2) 1-11
49. Sizova, D.; Charbaut, E.; Delalande, F.; Poirier, F.; High, A. A.; Parker, F.; Van Dorsselaer, A.; Duchesne, M.; Diu-Hercend, A. Proteomic analysis of brain tissue from an Alzheimer's disease mouse model by two-dimensional difference gel electrophoresis Neurobiol. Aging 2007, 28 (3) 357-70
50. Shimohama, S. Apoptosis in Alzheimer's disease - an update Apoptosis 2000, 5 (1) 9-16
51. Terry, R. D.; Masliah, E.; Salmon, D. P.; Butters, N.; DeTeresa, R.; Hill, R.; Hansen, L. A.; Katzman, R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment Ann. Neurol. 1991, 30 (4) 572-80
52. Bossy-Wetzel, E.; Barsoum, M. J.; Godzik, A.; Schwarzenbacher, R.; Lipton, S. A. Mitochondrial fission in apoptosis, neurodegeneration and aging Curr. Opin. Cell Biol. 2003, 15 (6) 706-716
53. Shevchenko, G.; Wetterhall, M.; Bergquist, J.; Hoglund, K.; Andersson, L. I.; Kultima, K. Longitudinal characterization of the brain proteomes for the Tg2576 amyloid mouse model using shotgun based mass spectrometry J. Proteome Res. 2012, 11 (12) 6159-6174
54. Chou, J. L.; Shenoy, D. V.; Thomas, N.; Choudhary, P. K.; LaFerla, F. M.; Goodman, S. R.; Breen, G. A. M. Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease J. Proteomics 2011, 74 (4) 466-479
55. Ng, F. W. H.; Nguyen, M.; Kwan, T.; Branton, P. E.; Nicholson, D. W.; Cromlish, J. A.; Shore, G. C. p28 Bap31, a Bcl-2/Bcl-X-L- and procaspase-8-associated protein in the endoplasmic reticulum J. Cell Biol. 1997, 139 (2) 327-338
56. Christen, Y. Oxidative stress and Alzheimer disease Am. J. Clin. Nutr. 2000, 71 (2) 621S-629S
57. Butterfield, D. A.; Boyd-Kimball, D.; Castegna, A. Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration J. Neurochem. 2003, 86 (6) 1313-27
58. Manevich, Y.; Sweitzer, T.; Pak, J. H.; Feinstein, S. I.; Muzykantov, V.; Fisher, A. B. 1-Cys peroxiredoxin overexpression protects cells against phospholipid peroxidation-mediated membrane damage Proc. Natl. Acad. Sci. U.S.A. 2002, 99 (18) 11599-604
59. Wang, X.; Phelan, S. A.; Forsman-Semb, K.; Taylor, E. F.; Petros, C.; Brown, A.; Lerner, C. P.; Paigen, B. Mice with targeted mutation of peroxiredoxin 6 develop normally but are susceptible to oxidative stress J. Biol. Chem. 2003, 278 (27) 25179-90
60. Yoo, B. C.; Kim, S. H.; Cairns, N.; Fountoulakis, M.; Lubec, G. Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease Biochem. Biophys. Res. Commun. 2001, 280 (1) 249-58
61. Papassotiropoulos, A.; Fountoulakis, M.; Dunckley, T.; Stephan, D. A.; Reiman, E. M. Genetics, transcriptomics, and proteomics of Alzheimer's disease J. Clin. Psychiatry 2006, 67 (4) 652-70
62. Roymans, D.; Vissenberg, K.; De Jonghe, C.; Grobben, B.; Claes, P.; Verbelen, J. P.; Van Broeckhoven, C.; Slegers, H. Phosphatidylinositol 3-kinase activity is required for the expression of glial fibrillary acidic protein upon cAMP-dependent induction of differentiation in rat C6 glioma J. Neurochem. 2001, 76 (2) 610-618
63. Casserly, I.; Topol, E. Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins Lancet 2004, 363 (9415) 1139-46
64. Flower, D. R. The lipocalin protein family-A role in cell regulation FEBS Lett. 1994, 354 (1) 7-11
65. Irshad, M.; Dubey, R. Apolipoproteins and their role in different clinical conditions: an overview Indian J. Biochem. Biophys. 2005, 42 (2) 73-80
66. Terrisse, L.; Poirier, J.; Bertrand, P.; Merched, A.; Visvikis, S.; Siest, G.; Milne, R.; Rassart, E. Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients J. Neurochem. 1998, 71 (4) 1643-1650
67. del Valle, E.; Navarro, A.; Astudillo, A.; Tolivia, J. Apolipoprotein D expression in human brain reactive astrocytes J. Histochem. Cytochem. 2003, 51 (10) 1285-90
68. Ordonez, C.; Navarro, A.; Perez, C.; Martinez, E.; del Valle, E.; Tolivia, J., Gender differences in apolipoprotein D expression during aging and in Alzheimer disease. Neurobiol. Aging 2012, 33, (2).
69. Thomas, E. A.; Laws, S. M.; Sutcliffe, J. G.; Harper, C.; Dean, B.; McClean, C.; Masters, C.; Lautenschlager, N.; Gandy, S. E.; Martins, R. N. Apolipoprotein D levels are elevated in prefrontal cortex of subjects with Alzheimer's disease: no relation to apolipoprotein E expression or genotype Biological psychiatry 2003, 54 (2) 136-41
70. Sudhof, T. C. The synaptic vesicle cycle Annu. Rev. Neurosci. 2004, 27, 509-547
71. Janz, R.; Sudhof, T. C.; Hammer, R. E.; Unni, V.; Siegelbaum, S. A.; Bolshakov, V. Y. Essential roles in synaptic plasticity for synaptogyrin I and synaptophysin I Neuron 1999, 24 (3) 687-700
72. Saetre, P.; Jazin, E.; Emilsson, L. Age-Related Changes in Gene Expression are Accelerated in Alzheimer's Disease Synapse 2011, 65 (9) 971-974
73. Suzuki, K.; Kawakami, F.; Sasaki, H.; Maruyama, H.; Ohtsuki, K. Biochemical characterization of tau protein and its associated syndapin 1 and protein kinase Cepsilon for their functional regulation in rat brain Biochim. Biophys. Acta 2009, 1790 (3) 188-97
74. Martin, H.; Rostas, J.; Patel, Y.; Aitken, A. Subcellular localisation of 14-3-3 isoforms in rat brain using specific antibodies J. Neurochem. 1994, 63 (6) 2259-65
75. Foote, M.; Zhou, Y. 14-3-3 proteins in neurological disorders Int J Biochem Mol Biol 2012, 3 (2) 152-64
76. Yamaguchi, M.; Kokai, Y.; Imai, S.; Utsumi, K.; Matsumoto, K.; Honda, H.; Mizue, Y.; Momma, M.; Maeda, T.; Toyomasu, S.; Ito, Y. M.; Kobayashi, S.; Hashimoto, E.; Saito, T.; Sohma, H. Investigation of Annexin A5 as a Biomarker for Alzheimer's Disease Using Neuronal Cell Culture and Mouse Model J. Neurosci. Res. 2010, 88 (12) 2682-2692
77. Maycox, P. R.; Link, E.; Reetz, A.; Morris, S. A.; Jahn, R. Clathrin-coated vesicles in nervous tissue are involved primarily in synaptic vesicle recycling J. Cell Biol. 1992, 118 (6) 1379-88
78. Nakamura, Y.; Takeda, M.; Yoshimi, K.; Hattori, H.; Hariguchi, S.; Kitajima, S.; Hashimoto, S.; Nishimura, T. Involvement of clathrin light chains in the pathology of Alzheimer's disease Acta Neuropathol. 1994, 87 (1) 23-31
79. Mata, A. M.; Berrocal, M.; Sepulveda, M. R. Impairment of the activity of the plasma membrane Ca2+-ATPase in Alzheimer's disease Biochem. Soc. Trans. 2011, 39, 819-822
80. Bezprozvanny, I.; Mattson, M. P. Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease Trends Neurosci. 2008, 31 (9) 454-463
81. de Diego, I.; Schwartz, F.; Siegfried, H.; Dauterstedt, P.; Heeren, J.; Beisiegel, U.; Enrich, C.; Grewal, T. Cholesterol modulates the membrane binding and intracellular distribution of annexin 6 J. Biol. Chem. 2002, 277 (35) 32187-94
82. Begcevic, I.; Kosanam, H.; Martinez-Morillo, E.; Dimitromanolakis, A.; Diamandis, P.; Kuzmanov, U.; Hazrati, L. N.; Diamandis, E. P. Semiquantitative proteomic analysis of human hippocampal tissues from Alzheimer's disease and age-matched control brains Clin. Proteomics 2013, 10 (1) 5
83. Gu, Y.; Hamajima, N.; Ihara, Y. Neurofibrillary tangle-associated collapsin response mediator protein-2 (CRMP-2) is highly phosphorylated on Thr-509, Ser-518, and Ser-522 Biochemistry 2000, 39 (15) 4267-75
84. Sultana, R.; Robinson, R. A.; Lange, M. B.; Fiorini, A.; Galvan, V.; Fombonne, J.; Baker, A.; Gorostiza, O.; Zhang, J.; Cai, J.; Pierce, W. M.; Bredesen, D. E.; Butterfield, D. A. Do proteomics analyses provide insights into reduced oxidative stress in the brain of an Alzheimer disease transgenic mouse model with an M631L amyloid precursor protein substitution and thereby the importance of amyloid-beta-resident methionine 35 in Alzheimer disease pathogenesis? Antioxid. Redox. Signal. 2012, 17 (11) 1507-14
85. Bogdanovic, N.; Davidsson, P.; Volkmann, I.; Winblad, B.; Blennow, K. Growth-associated protein GAP-43 in the frontal cortex and in the hippocampus in Alzheimer's disease: an immunohistochemical and quantitative study J. Neural Transm. 2000, 107 (4) 463-78
86. Zhou, W.; Scott, S. A.; Shelton, S. B.; Crutcher, K. A. Cathepsin D-mediated proteolysis of apolipoprotein E: possible role in Alzheimer's disease Neuroscience 2006, 143 (3) 689-701
87. Togashi, H.; Sakisaka, T.; Takai, Y. Cell adhesion molecules in the central nervous system Cell. Adhes. Migr. 2009, 3 (1) 29-35
88. Todaro, L.; Puricelli, L.; Gioseffi, H.; Guadalupe Pallotta, M.; Lastiri, J.; Bal de Kier Joffe, E.; Varela, M.; Sacerdote de Lustig, E. Neural cell adhesion molecule in human serum. Increased levels in dementia of the Alzheimer type Neurobiol. Dis. 2004, 15 (2) 387-93
89. Bishop, G. M.; Robinson, S. R. Human Abeta1-42 reduces iron-induced toxicity in rat cerebral cortex J. Neurosci. Res. 2003, 73 (3) 316-23
90. Li, X.; Liu, Y.; Zheng, Q.; Yao, G.; Cheng, P.; Bu, G.; Xu, H.; Zhang, Y. W. Ferritin light chain interacts with PEN-2 and affects gamma-secretase activity Neurosci. Lett. 2013, 548, 90-4